Hims & Hers Health Enhances Governance with New Board Appointments

Hims & Hers Health Strengthens Governance with New Board Appointments

Hims & Hers Health announces significant changes to its Board of Directors as it prepares for future challenges in the evolving healthcare landscape. Eileen A. Kamerick is appointed as the new Chair of the Board, effective November 15, 2024, succeeding Jane Trust, who will continue as an interested Director. Kamerick, who has served as an independent Director since 2013, brings a wealth of experience in corporate governance and financial strategy. Her previous roles include Chief Financial Officer at well-respected firms such as Houlihan Lokey and BP Amoco Americas, positioning her to guide the Board with a seasoned perspective in navigating the complexities of the modern healthcare environment.

The Board also welcomes three new Directors: Anthony Grillo, Peter Mason, and Hillary Sale. Grillo, a founding member of the American Securities Opportunity Funds, has a long-standing career as a Managing Director until 2018 and currently serves on the board of Littelfuse, Inc. His financial acumen adds valuable insight to the Board's strategic direction. Mason, an international commercial arbitrator since 2021, previously held the role of global General Counsel at UNICEF, where he chaired the Investment Committee for a retiree benefits fund. His legal expertise will be instrumental in addressing regulatory challenges and ensuring adherence to best practices in governance.

Hillary Sale, a prominent academic in corporate governance, has been a professor at Georgetown University Law Center since 2018 and has served on various regulatory boards, including FINRA. Her academic insights and regulatory experience will enhance the Board's ability to foster responsible governance and ethical standards. Collectively, these appointments reflect Hims & Hers Health's commitment to assembling a diverse and experienced team that can adeptly manage the intricate landscape of healthcare services and innovations.

In addition to these appointments, the Board emphasizes its focus on strong governance and leadership, which is crucial for navigating the increasing complexities within the healthcare sector. As the company continues to expand its services and adapt to market demands, the expertise brought by Kamerick and the new Directors positions Hims & Hers Health for sustainable growth and success.

For those interested in more information regarding the company or its governance structure, Hims & Hers Health encourages inquiries via their website or by phone. The strategic enhancement of the Board underscores the company’s dedication to maintaining high standards in corporate governance and financial management as it seeks to innovate in the health and wellness space.